Sandoz Recalls Aprepitant Capsules and Lidocaine and Prilocaine Cream Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning
The recalled prescription drugs and products that contain lidocaine must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
Related posts:
Polaris Recalls RZR Recreational Off-Road Vehicles Due to Fire Hazard (Recall Alert)March 29, 2023
More than 1.2 Million Mainstays Three-Wick Candles Recalled by Star Soap Star Candle Prayer Candle D...February 22, 2023
Burnham Commercial Recalls Natural Gas Boilers Due to Burn Hazard (Recall Alert)March 22, 2023
Views: 0